1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Leukemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denizot, Y; Donnard, M; Guglielmi, L; Trimoreau, F | 1 |
| Bordessoule, D; Denizot, Y; Donnard, M; Trimoreau, F; Truffinet, V; Turlure, P; Vincent, C | 1 |
| Bussolino, F; Camussi, G; Ferrando, ML; Foa, R; Malavasi, F | 1 |
| Hajdu, J; Hoffman, DR; Snyder, F | 1 |
| Berchtold, R; Hoffman, DR; Snyder, F; Stanley, JD | 1 |
| Blank, ML; Cabot, MC; Cress, EA; Horan, MJ; Snyder, F; Welsh, CJ | 1 |
| Denizot, Y; Dupuis, F; Praloran, V; Trimoreau, F; Verger, C | 1 |
| Denizot, Y; Dupuis, F; Liozon, E; Praloran, V; Trimoreau, F | 1 |
| Alonso-Torre, SR; Alvarez, J; García-Sancho, J; Montero, M; Sanchez, A | 1 |
| Bianchi, L; Cellai, C; Della Malva, N; Laurenzana, A; Paoletti, F; Vannucchi, AM | 1 |
| Bittman, R; Dryden, P; Howard, S; Salari, H | 1 |
| Aglietta, M; Aprá, F; Bussolino, F; Gavosto, G; Monzeglio, C; Mossetti, C; Piacibello, W; Sanavio, F; Stacchini, A | 1 |
| Hanahan, DJ | 1 |
| Berdel, WE; Busch, R; Danhauser, S; Eibl, H; Fink, U; Fromm, M; Rastetter, J; Reichert, A; Schick, HD | 1 |
| Berdel, WE; Eibl, H; Fink, U; Fromm, M; Jehn, U; Rastetter, J; Reichert, A; Schick, HD; Ulm, K; Unger, C | 1 |
| Bussolino, F; Camussi, G; Ferrando, ML; Foa, R; Guarini, A; Gugliotta, L; Mazzone, R; Tetta, C | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukemia
| Article | Year |
|---|---|
Platelet-activating factor and normal or leukaemic haematopoiesis.
Topics: B-Lymphocytes; Hematopoiesis; Humans; Leukemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction | 2003 |
[GM-CSF: target cells and their response kinetics].
Topics: Bone Marrow; Cell Division; Cells, Cultured; Colony-Stimulating Factors; Endothelium; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells; Organ Specificity; Platelet Activating Factor; Recombinant Proteins; Tumor Cells, Cultured | 1989 |
Platelet activating factor: a biologically active phosphoglyceride.
Topics: Animals; Blood Platelets; Capillary Permeability; Chemical Phenomena; Chemistry; Exocrine Glands; Humans; Hypotension; Intestinal Diseases; Leukemia; Liver; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1986 |
13 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukemia
| Article | Year |
|---|---|
No effect of platelet-activating factor on the proliferation and apoptosis of immature forms of leukemic blasts.
Topics: Apoptosis; Blast Crisis; Cell Proliferation; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukocytes; Platelet Activating Factor; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2007 |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines.
Topics: B-Lymphocytes; Burkitt Lymphoma; Cell Line; HLA Antigens; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Platelet Activating Factor; T-Lymphocytes | 1984 |
Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Fibroblasts; Humans; Kinetics; L-Lactate Dehydrogenase; Leukemia; Neutrophils; Platelet Activating Factor; Serum Albumin, Bovine; Skin | 1984 |
Cytotoxicity of ether-linked phytanyl phospholipid analogs and related derivatives in human HL-60 leukemia cells and polymorphonuclear neutrophils.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Cells, Cultured; Humans; Isomerism; L-Lactate Dehydrogenase; Leukemia; Neutrophils; Phospholipids; Platelet Activating Factor; Structure-Activity Relationship | 1984 |
Metabolism of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by cell cultures.
Topics: Animals; Cattle; Cells, Cultured; Dogs; Humans; Kidney; Leukemia; Mice; Platelet Activating Factor | 1982 |
Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Aged; Bone Marrow; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Adolescent; Adult; Aged; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores.
Topics: Antifungal Agents; Biological Transport; Calcium; Cell Differentiation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytosol; Dimethyl Sulfoxide; Econazole; Humans; Imidazoles; Ionomycin; Leukemia; Manganese; N-Formylmethionine Leucyl-Phenylalanine; Nickel; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Receptors, Immunologic; Tumor Cells, Cultured | 1993 |
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; K562 Cells; Kinetics; Leukemia; Leukemia, Erythroblastic, Acute; Mice; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Triazoles; Tumor Cells, Cultured | 2002 |
Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
Topics: Animals; Antineoplastic Agents; Glycerylphosphorylcholine; Humans; Leukemia; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 1992 |
Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Topics: Antineoplastic Agents; Cell Survival; Cytotoxins; Glyceryl Ethers; Humans; Leukemia; Lysophospholipids; Organophosphates; Phospholipid Ethers; Platelet Activating Factor; Tumor Cells, Cultured | 1987 |
Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Survival; Cytotoxins; Humans; Leukemia; Organophosphates; Phospholipid Ethers; Platelet Activating Factor; Thymidine; Tumor Cells, Cultured | 1987 |
Release of platelet-activating factor in human leukemia.
Topics: Animals; Cell Differentiation; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Platelet Activating Factor; Rabbits | 1985 |